Patents
Sitemap › C07 - Organic chemistry › C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids › C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
08/1995
08/10/1995WO1995021254A1 Multivariant il-3 hematopoiesis fusion protein
08/10/1995WO1995021251A1 T-cell antigens, and their use in diagnosis and treatment of t-cell mediated conditions
08/10/1995WO1995021245A1 Nucleic acid encoding neuropeptide y/peptide yy (y2) receptors and uses thereof
08/10/1995WO1995021195A1 Non-viral vector
08/10/1995WO1995021189A1 Hepatitis b vaccine
08/10/1995WO1995021184A1 Substituted purines and oligonucleotide cross-linking
08/10/1995WO1995021179A1 Endotoxin reduction or removal process
08/10/1995WO1995021177A1 Process for producing endotoxin-free or endotoxin-poor nucleic acids and/or oligonucleotides for gene therapy
08/10/1995WO1995020974A1 Monoclonal anbibodies which bind to tumor rejection antigen precursor mage-1, recombinant mage-1, and mage-1 derived immunogenic peptides
08/10/1995WO1995015373A3 Inhibition of dna methyltransferase
08/10/1995DE4403779A1 Prepn. of dye-bio-molecule conjugates
08/10/1995CA2182685A1 T-cell antigens, and their use in diagnosis and treatment of t-cell mediated conditions
08/10/1995CA2182616A1 Non-viral vector
08/10/1995CA2182484A1 Multivariant il-3 hematopoiesis fusion protein
08/10/1995CA2182375A1 Hepatitis b vaccine
08/10/1995CA2182369A1 Monoclonal anbibodies which bind to tumor rejection antigen precursor mage-1, recombinant mage-1, and mage-1 derived immunogenic peptides
08/10/1995CA2159217A1 Nucleic acid encoding neuropeptide y/peptide yy (y2) receptors and uses thereof
08/09/1995EP0666317A2 Antisense oligonucleotides against HSV-1 and their preparation
08/09/1995EP0665898A1 Angiotensinogen gene variants and predisposition to hypertension
08/09/1995EP0665897A1 Complex combinatorial chemical libraries encoded with tags
08/09/1995EP0665892A1 Enhanced indole biosynthesis
08/09/1995EP0665885A1 Polypeptides (5ht2c) having a serotoninergic receptor activity and uses thereof
08/08/1995US5439794 Spectroscopically or photoactively determination when bound to Dna
08/08/1995US5439679 Peptide plasminogen activators
08/08/1995US5439570 Water soluble texaphyrin metal complexes for singlet oxygen production
08/05/1995CA2141907A1 Virus msrvl and pathogen agent and/or msrv2 associated with multiple sclerosis, their nucleic constituants and their applications
08/03/1995WO1995020681A1 Comparative gene transcript analysis
08/03/1995WO1995020665A1 Expression of heterologous proteins in attenuated bacteria using the htra-promoters
08/03/1995WO1995020664A2 Mammalian expression systems for hepatitis c virus envelope genes
08/03/1995WO1995020660A2 Immunization by inoculation of dna transcription unit
08/03/1995WO1995020659A1 MODIFIED PAPILLOMA VIRUS L2 PROTEIN AND VLPs FORMED THEREFROM
08/03/1995WO1995020658A2 Diagnosis and treatment of infections due to streptococci and enterococci
08/03/1995WO1995020656A1 Diagnosis of metastatic cancer by the mts-1 gene
08/03/1995WO1995020655A1 Novel cell surface receptor, antibody compositions, and methods of using same
08/03/1995WO1995020597A1 Modified oligonucleotides
08/03/1995WO1995020595A1 L-nucleosides for the treatment of hepatitis b-virus and epstein-bar virus
08/03/1995WO1995020594A1 Purification of plant-derived polynucleotides
08/03/1995WO1995020404A1 Triplex-forming paired-ion oligonucleotides and methods for preparing and using same
08/03/1995WO1995020398A1 Human growth hormone
08/03/1995WO1995020320A1 Self-assembling multimeric nucleic acid constructs
08/03/1995WO1995015971A3 Nucleic acid mediated electron transfer
08/03/1995WO1995007918A3 Pyrimidine derivatives for labeled binding partners
08/03/1995CA2182217A1 Comparative gene transcript analysis
08/03/1995CA2182205A1 Human growth hormone
08/03/1995CA2182170A1 Mammalian expression systems for hepatitis c virus envelope genes
08/03/1995CA2181062A1 Diagnosis of metastatic cancer by the mts-1 gene
08/03/1995CA2180727A1 Modified oligonucleotides
08/03/1995CA2180443A1 Novel cell surface receptor, antibody compositions, and methods of using same
08/02/1995EP0665289A2 Peptides from GAD65, provoking autoimmune reactions
08/02/1995EP0527184B1 Phosphoramidite derivatives, their preparation and the use thereof in the incorporation of reporter groups on synthetic oligonucleotides
08/01/1995US5438131 Universal nucleosides for use as constituents of oligonucleotide probes
08/01/1995US5438127 DNA purification by solid phase extraction using a PCl3 modified glass fiber membrane
08/01/1995US5437990 Selective amplification of target polynucleotide sequences
08/01/1995US5437865 Isolated sialylated glycoprotein endosialin, which is expressed by tumor associated vascular endothelium
08/01/1995US5437864 Removing blood from patient, administering a monoclonal antibody to neutralization
08/01/1995CA1336509C Polypeptide possessing isoamylase activity, and its uses
07/1995
07/27/1995WO1995020161A1 Homogeneous immunoassays and enzyme based assays of analytes using capillary electrophoresis
07/27/1995WO1995020055A1 NUCLEIC ACID PROBES FOR THE DETECTION OF $i(HAEMOPHILUS INFLUENZAE)
07/27/1995WO1995020049A1 Herpesvirus pre-(viral dna replication) enveloped
07/27/1995WO1995020048A1 Secretion of proteins from the outer membrane of gram-negative bacteria by gram-positive host organisms
07/27/1995WO1995020045A1 Antibodies to egf receptor and their antitumour effect
07/27/1995WO1995019985A1 Haemopoietic maturation factor
07/27/1995WO1995019790A1 Humanized antibodies against leukocyte adhesion molecule vla-4
07/27/1995WO1995019785A1 Treatment for juvenile diabetes
07/27/1995WO1995019779A1 Deltex proteins, nucleic acids, and antibodies, and related methods and compositions
07/27/1995WO1995014778A3 Dna sequence coding for a bmp receptor
07/27/1995CA2181431A1 Haemopoietic maturation factor
07/27/1995CA2180834A1 Antibodies to egf receptor and their antitumour effect
07/26/1995EP0663954A1 Ptp 1d: a novel protein tyrosine phosphatase
07/26/1995CN1105668A Hepatitis A virus attenuated live vaccine complementary DNA sequence
07/25/1995US5436331 Protection of hydroxy function with 1-N-aryl-4-alkoxy-piperidin-4-yl
07/25/1995US5436328 Nucleic acids extraction using binders and exchanging to dissociate
07/25/1995US5436327 Support-bound oligonucleotides
07/25/1995US5436162 Human manganese superoxide dismutase (hMn-SOD)
07/25/1995US5436157 Human intra-acrosomal sperm antigen
07/25/1995US5436149 Thermostable DNA polymerase with enhanced thermostability and enhanced length and efficiency of primer extension
07/25/1995US5436143 Genetic engineering; one vessel; enzyme deactivation
07/25/1995US5436142 Methods for producing probes capable of distingushing variant genomic sequences
07/25/1995US5436139 Non-passageable virus
07/25/1995CA1336394C Detection and amplification of target nucleic acid sequences
07/21/1995CA2140591A1 Antigen-specific, activated t lymphocytes, detection and use
07/20/1995WO1995019438A1 Equine arteritis virus peptides, antibodies and their use in a diagnostic test
07/20/1995WO1995019436A1 Mammalian monocyte chemoattractant protein receptors
07/20/1995WO1995019434A1 Tissue-specific enhancer active in prostate
07/20/1995WO1995019433A2 Anti-hepatitis b poly- and oligonucleotides
07/20/1995WO1995019431A1 Zinc finger protein derivatives and methods therefor
07/20/1995WO1995019429A2 Method and reagent for inhibiting hepatitis c virus replication
07/20/1995WO1995019371A2 Expression of surface layer proteins
07/20/1995WO1995019183A1 Cd44 expression in smooth muscle cells
07/20/1995WO1995019180A1 Anti-gram-positive bacterial methods and materials
07/20/1995WO1995019179A1 Anti-fungal methods and materials
07/20/1995WO1995019175A1 Antisense oligonucleotides specific for stk-1 and method for inhibiting expression of the stk-1 protein
07/20/1995WO1995019167A1 Therapeutic treatment for inhibiting vascular restenosis
07/20/1995WO1995016696A3 Modified oligonucleotides, method for producing them and use as active substances
07/20/1995WO1995007995A3 Adeno-associated viral (aav) liposomes and methods related thereto
07/20/1995CA2210396A1 Method for detection and treatment of breast cancer
07/20/1995CA2181276A1 Antisense oligonucleotides specific for stk-1 and method for inhibiting expression of the stk-1 protein
07/20/1995CA2181159A1 Equine arteritis virus peptides, antibodies and their use in a diagnostic test
07/20/1995CA2181035A1 Therapeutic treatment for inhibiting vascular restenosis
07/20/1995CA2180740A1 Method and reagent for inhibiting hepatitis c virus replication
1 ... 834 835 836 837 838 839 840 841 842 843 844 845 846 847 848 849 850 851 852 853 854 ... 899